Attendance
|
Category
|
Names
|
|
Members of the Senedd:
|
Peter Fox MS (Chair)
Mabon ap Gwynfor MS
John Griffiths MS
|
|
Witnesses:
|
|
|
Committee Staff:
|
Sarah Beasley (Clerk)
Karen Williams (Deputy Clerk)
Sarah Hatherley (Researcher)
|
<AI1>
1
Introductions, apologies, substitutions,
and declarations of interest
1.1
The Chair welcomed Members to the meeting.
1.2
Apologies were received from Joyce Watson MS.
1.3
The Chair thanked Russell George MS for his work on the Committee
and wished him well in his new role.
1.4
The Chair paid tribute to Claire O’Shea and recognised her
invaluable contribution to the Committee’s inquiry into
gynaecological cancer, and her determination to see changes made to
the way that women's health is treated.
</AI1>
<AI2>
2
Ophthalmology Services in Wales -
evidence session - panel 5
2.1 The Committee heard evidence from Digital
Health and Care Wales (DHCW); and digital directorate
representatives from Cardiff & Vale University Health Board
(CAVUHB).
</AI2>
<AI3>
3
Ophthalmology Services in Wales -
evidence session - panel 6
3.1 The Committee heard evidence from
representatives of Local Health Boards.
</AI3>
<AI4>
4
Papers to note
</AI4>
<AI5>
4.1
Letter to Cabinet Secretary for Health
and Social Care requesting an update on the actions being taken to
improve complaints handling by NHS Wales
4.1.1 The Committee noted the letter.
</AI5>
<AI6>
4.2
Reply from Cabinet Secretary for Health
and Social Care regarding actions to improve handling of complaints
about NHS Wales
4.2.1 The Committee noted the response.
</AI6>
<AI7>
4.3
Welsh Government's response to the
Committee's report on the Legislative Consent Memorandum for the
Tobacco & Vapes Bill
4.3.1 The Committee noted the response.
</AI7>
<AI8>
4.4
Letter from Tenovus Cancer Care regarding
request to hold a short inquiry into the implementation of the
Committee's report on gynaecological cancers
4.4.1 The Committee noted the letter.
</AI8>
<AI9>
4.5
Letter to Tenovus Cancer Care regarding
request to hold a short inquiry into the implementation of the
Committees' report on gynaecological cancers
4.5.1 The Committee noted the letter.
</AI9>
<AI10>
4.6
Letter from Tenovus Cancer care and
Claire's Campaign, regarding request for short inquiry into the
implementation oof the Committees' report on gynaecological
cancers
4.6.1 The Committee noted the response.
</AI10>
<AI11>
4.7
Letter from the Petitions Committee re
petition: P-06-1435: We’re calling on the Welsh Government to
commit to implementing targeted lung cancer screening
4.7.1 The Committee noted the letter.
</AI11>
<AI12>
4.8
Letter from the Minister for Children and
Social Care in response to stage one scrutiny report on the Health
and Social Care (Wales) Bill and recommendations associated with
the eliminating profit provisions contained within the
legislation
4.8.1 The Committee noted the letter.
</AI12>
<AI13>
4.9
Letter to Welsh Local Government
Association requesting information to inform the inquiry into
prevention of ill health –obesity
4.9.1 The Committee noted the letter.
</AI13>
<AI14>
4.10 Reply
from Welsh Local Government Association providing information to
inform the inquiry into prevention of ill health-
obesity
4.10.1 The Committee noted the response.
</AI14>
<AI15>
4.11 Letter
from the Minister for Children and Social Care in response to
Health and Social Care (Wales) Bill report, recommendation 9, on
the progress being made with the transition to a not-for-profit
model
4.11.1 The Committee noted the letter.
</AI15>
<AI16>
4.12 Letter to
NHS Wales Chief Executive regarding the NHS Executive Strategic
Clinical Network for Diabetes
4.12.1 The Committee noted the letter.
</AI16>
<AI17>
4.13 Reply
from the NHS Wales Chief Executive regarding the NHS
Executive Strategic Clinical Network for Diabetes
4.13.1 The Committee noted the response.
</AI17>
<AI18>
5
Motion under Standing Order 17.42 (ix) to
resolve to exclude the public from the remainder of this
meeting
5.1. The Committee agreed the motion.
</AI18>
<AI19>
6
Ophthalmology Services in Wales:
consideration of evidence
6.1 The Committee considered the evidence
received.
</AI19>
<TRAILER_SECTION>
</TRAILER_SECTION>
<LAYOUT_SECTION>
1.
FIELD_TITLE
FIELD_SUMMARY
</LAYOUT_SECTION>
<TITLE_ONLY_LAYOUT_SECTION>
2.
FIELD_TITLE
</TITLE_ONLY_LAYOUT_SECTION>
<HEADING_LAYOUT_SECTION>
FIELD_TITLE
</HEADING_LAYOUT_SECTION>
<TITLED_COMMENT_LAYOUT_SECTION>
FIELD_TITLE
FIELD_SUMMARY
</TITLED_COMMENT_LAYOUT_SECTION>
<COMMENT_LAYOUT_SECTION>
FIELD_SUMMARY
</COMMENT_LAYOUT_SECTION>
<SUBNUMBER_LAYOUT_SECTION>
2.1
FIELD_TITLE
FIELD_SUMMARY
</SUBNUMBER_LAYOUT_SECTION>
<TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>
2.2
FIELD_TITLE
</TITLE_ONLY_SUBNUMBER_LAYOUT_SECTION>